Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1269 of 5804
-
Can faster brain zaps beat depression in seniors?
Symptom relief Recruiting nowThe purpose of this trial is to compare the treatment efficacy (improvement in depressive symptoms) of accelerated TBS protocol (where participants receive multiple TBS treatments daily) to conventional TBS protocol (where participants receive a single TBS treatment daily) in lat…
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New study tests switch from IV to At-Home shots for gut disease
Disease control Recruiting nowUlcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disapp…
Phase: PHASE4 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a diabetes drug boost bariatric surgery results?
Disease control Recruiting nowThis clinical trial will test whether preoperative tirzepatide treatment improves outcomes after bariatric surgery. The outcome of this study could impact therapeutic guidelines for the multimodal treatment of obesity. The major objectives are: 1. To evaluate whether pre-operat…
Phase: PHASE4 • Sponsor: Marlene Starr • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control OngoingGH2616 is a potent and selective inhibitor targeting KIF18A, exhibiting distinct and superior anticancer properties compared to other cell cycle and anti-mitotic drug targets, with significant inhibitory effects on TP53 mutant and WGD (whole genome doubling) or CIN (chromosomal i…
Phase: PHASE1 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New Long-Acting HIV shot shows promise for kids and teens
Disease control Recruiting nowThe goal of this clinical study is to learn more about the study drug, lenacapavir (LEN). The study will assess the safety, tolerability, and efficacy of long-acting LEN when combined with other medicines in adolescents and children living with HIV-1 who weigh at least 35 kg and …
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New Dual-Action antibody takes on advanced cancers
Disease control Recruiting nowBIPAVE-001 is a Phase 1-2 study for evaluating the safety, pharmacokinetics (PK), and efficacy of AI-081 in solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for bladder control: magnetic or electric pulses may reduce accidents
Symptom relief Recruiting nowThe goal of this prospective, randomized clinical trial is to compare the efficacy and safety of transcutaneous sacral magnetic stimulation versus sacral electrical stimulation for detrusor overactivity in 40 male and female patients aged 18-65 with suprasacral Spinal Cord Injury…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New spine procedure tracked in 1,500 patients for back pain relief
Symptom relief Recruiting nowCompile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New pill aims to tame both ADHD and anxiety in one daily dose
Disease control CompletedPrimary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults ages with ADHD and comorbid anxiety
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New asthma drug aims to cut severe attacks in patients not helped by inhalers
Disease control Recruiting nowThis is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Immune cells take aim at Post-Transplant virus
Disease control Recruiting nowThis exploratory clinical study focuses on the use of EBV-AST cell infusion for treating EBV-DNA viremia following allogeneic hematopoietic stem cell transplantation (Allo-HSCT). The study aims to determine the maximum tolerated dose (MTD) or optimal biological dose (OBD) of EBV-…
Phase: PHASE1, PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Red wine without the alcohol: a new weapon against aging?
Disease control Recruiting nowPolyphenols, precisely resveratrol, with red wine as the most substantial source, was associated with improvements in cognitive function. Also, the loss of muscle mass and strength in elderly, that significantly increases dependency of these people, it could be attributed to alte…
Phase: NA • Sponsor: University Rovira i Virgili • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Massive study aims to catch cancer early with genetic screening
Knowledge-focused Recruiting nowThe primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which…
Sponsor: ClinLogic LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Could this pill delay Parkinson's progression? new trial begins
Symptom relief OngoingThe goal of this clinical trial is to learn if bezisterim can treat movement symptoms of Parkinson's disease in patients that are 45 to 80 years old, in generally good physical and mental health, and are nearing the need for treatment to relieve their symptoms but have not yet be…
Phase: PHASE2 • Sponsor: BioVie Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Radiation instead of surgery? new trial for elderly breast cancer patients
Disease control Recruiting nowStereotactic body radiotherapy (SBRT) is a modern radiotherapy technique, through which extremely high doses of irradiation are delivered in a very precise manner, within a few fractions. SBRT is increasingly used into clinical practice because it can provide excellent local cont…
Phase: NA • Sponsor: University Hospital, Geneva • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for advanced cancer? early trial tests MK-3120
Disease control Recruiting nowResearchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has spread to other parts of the body and cannot be removed with surgery. Solid tumors are cancers mostly in body organs and tissues, not in the blood or other body …
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New pill aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this open-label dose escalation and expansion study is to evaluate the safety and tolerability of NKT5097 in adults with advanced/metastatic tumors (emphasis on breast cancer and solid tumors with CCNE1 amplification). Main questions to answer include: * What is the …
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New online program aims to boost stroke recovery and ease caregiver strain
Symptom relief Recruiting nowStroke is a leading cause of long-term disability. Research has placed little emphasis on integrating care partners (CP) (family members) into the rehabilitation process without increasing negative care partner outcomes. The research team has developed and implemented a novel, we…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New pill could stop PTSD before it starts after car crashes
Symptom relief Recruiting nowThis study will examine the safety and efficacy of TNX-102 SL to reduce ASR symptoms and behavioral changes among patients presenting to the emergency department (ED) after motor vehicle collision (MVC). Specifically, the investigators will perform the Optimizing Acute Stress rea…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can a single drug boost blood counts and delay cancer in High-Risk patients?
Disease control Recruiting nowThe purpose of this clinical trial is to test how well the drug luspatercept works in improving low blood cell counts in people with clonal cytopenias of uncertain significance (CCUS). The main questions the study seeks to answer include: * How many patients experience improveme…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC